Eisai CEO on Alzheimer's treatment drug trial results

2:19 PM ET Thu, 26 July 2018

Ivan Cheung, Eisai U.S. chairman and CEO, speaks exclusively with "Power Lunch" and CNBC's Meg Tirrell about the drug trial for an Alzheimer's treatment from Biogen and Eisai.